142 related articles for article (PubMed ID: 38373978)
21. Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma.
Xiao L; Zou G; Cheng R; Wang P; Ma K; Cao H; Zhou W; Jin X; Xu Z; Huang Y; Lin X; Nie H; Jiang Q
BMC Cancer; 2021 Jun; 21(1):703. PubMed ID: 34130646
[TBL] [Abstract][Full Text] [Related]
22. SKI activates the Hippo pathway via LIMD1 to inhibit cardiac fibroblast activation.
Landry NM; Rattan SG; Filomeno KL; Meier TW; Meier SC; Foran SJ; Meier CF; Koleini N; Fandrich RR; Kardami E; Duhamel TA; Dixon IMC
Basic Res Cardiol; 2021 Apr; 116(1):25. PubMed ID: 33847835
[TBL] [Abstract][Full Text] [Related]
23. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
[TBL] [Abstract][Full Text] [Related]
24. Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma.
Cheng L; Mi J; Zhang J; Huang H; Mo Z
Clin Transl Oncol; 2024 Jan; 26(1):119-135. PubMed ID: 37261660
[TBL] [Abstract][Full Text] [Related]
25. LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription.
Xie X; Lin J; Fan X; Zhong Y; Chen Y; Liu K; Ren Y; Chen X; Lai D; Li X; Li Z; Tang A
Cell Death Dis; 2021 Feb; 12(2):201. PubMed ID: 33608495
[TBL] [Abstract][Full Text] [Related]
26. Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification.
Zhang Y; Zhang Z; Zhang W; Hu H; Bao G
Dis Markers; 2021; 2021():7694239. PubMed ID: 34868397
[TBL] [Abstract][Full Text] [Related]
27. Cuproptosis status affects treatment options about immunotherapy and targeted therapy for patients with kidney renal clear cell carcinoma.
Zhang G; Chen X; Fang J; Tai P; Chen A; Cao K
Front Immunol; 2022; 13():954440. PubMed ID: 36059510
[TBL] [Abstract][Full Text] [Related]
28. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma.
Chen CC; Chu PY; Lin HY
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154
[TBL] [Abstract][Full Text] [Related]
29. Identification of the key genes and pathways involved in the tumorigenesis and prognosis of kidney renal clear cell carcinoma.
Cui H; Shan H; Miao MZ; Jiang Z; Meng Y; Chen R; Zhang L; Liu Y
Sci Rep; 2020 Mar; 10(1):4271. PubMed ID: 32144299
[TBL] [Abstract][Full Text] [Related]
30. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
[TBL] [Abstract][Full Text] [Related]
31. Induction of AP-1 by YAP/TAZ contributes to cell proliferation and organ growth.
Koo JH; Plouffe SW; Meng Z; Lee DH; Yang D; Lim DS; Wang CY; Guan KL
Genes Dev; 2020 Jan; 34(1-2):72-86. PubMed ID: 31831627
[TBL] [Abstract][Full Text] [Related]
32. TAZ facilitates breast tumor growth by promoting an immune-suppressive tumor microenvironment.
Gershoni A; Hassin O; Nataraj NB; Baruch S; Avioz-Seligman A; Pirona AC; Fellus-Alyagor L; Meir Salame T; Mukherjee S; Mallel G; Yarden Y; Aylon Y; Oren M
Mol Oncol; 2023 Dec; 17(12):2675-2693. PubMed ID: 37716913
[TBL] [Abstract][Full Text] [Related]
33. LINC00997, a novel long noncoding RNA, contributes to metastasis via regulation of S100A11 in kidney renal clear cell carcinoma.
Chang Y; Li N; Yuan W; Wang G; Wen J
Int J Biochem Cell Biol; 2019 Nov; 116():105590. PubMed ID: 31442606
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive investigation discovered the novel methyltransferase METTL24 as one presumably prognostic gene for kidney renal clear cell carcinoma potentially modulating tumor immune microenvironment.
Jiang Z; Zhang W; Zeng Z; Tang D; Li C; Cai W; Chen Y; Li Y; Jin Q; Zhang X; Yin L; Liu X; Xu Y; Dai Y
Front Immunol; 2022; 13():926461. PubMed ID: 36311770
[TBL] [Abstract][Full Text] [Related]
35. MITD1 Deficiency Suppresses Clear Cell Renal Cell Carcinoma Growth and Migration by Inducing Ferroptosis through the TAZ/SLC7A11 Pathway.
Zhang Y; Li Y; Qiu Q; Chen Z; Du Y; Liu X
Oxid Med Cell Longev; 2022; 2022():7560569. PubMed ID: 36046690
[TBL] [Abstract][Full Text] [Related]
36. Studying the Geroprotective Properties of YAP/TAZ Signaling Inhibitors on
Golubev DA; Zemskaya NV; Gorbunova AA; Kukuman DV; Moskalev A; Shaposhnikov MV
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983079
[TBL] [Abstract][Full Text] [Related]
37. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.
Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA
J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639
[TBL] [Abstract][Full Text] [Related]
38. Hippo signaling effectors YAP and TAZ induce Epstein-Barr Virus (EBV) lytic reactivation through TEADs in epithelial cells.
Van Sciver N; Ohashi M; Pauly NP; Bristol JA; Nelson SE; Johannsen EC; Kenney SC
PLoS Pathog; 2021 Aug; 17(8):e1009783. PubMed ID: 34339458
[TBL] [Abstract][Full Text] [Related]
39. A Division of Labor between YAP and TAZ in Non-Small Cell Lung Cancer.
Shreberk-Shaked M; Dassa B; Sinha S; Di Agostino S; Azuri I; Mukherjee S; Aylon Y; Blandino G; Ruppin E; Oren M
Cancer Res; 2020 Oct; 80(19):4145-4157. PubMed ID: 32816858
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic inactivation of ACAT1 promotes epithelial-mesenchymal transition of clear cell renal cell carcinoma.
Han P; Wu S; Li L; Li D; Zhao J; Zhang H; Wang Y; Zhong X; Zhang Z; Li P; Matskova L; Zhou X
Genes Genomics; 2022 Apr; 44(4):487-497. PubMed ID: 34985712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
